Literature DB >> 4280020

Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.

B Costall, R J Naylor.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4280020     DOI： 10.1007/bf00499529

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  22 in total

Review 1.  Drugs affecting monoamines in the basal ganglia.

Authors:  G Bartholini; A Pletscher
Journal:  Adv Biochem Psychopharmacol       Date:  1972

2.  Modification of the behavioural changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus.

Authors:  R J Naylor; J E Olley
Journal:  Neuropharmacology       Date:  1972-01       Impact factor: 5.250

Review 3.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

Authors:  O Hornykiewicz
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

4.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Action of various centrally acting agents in mice with unilateral caudate brain lesions.

Authors:  V J Lotti
Journal:  Life Sci I       Date:  1971-07-15

6.  Evidence for a new type of dopamine receptor stimulating agent.

Authors:  H Corrodi; K Fuxe; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

7.  The site and mode of action of ET495 for the mediation of stereotyped behaviour in the rat.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  The role of telencephalic dopaminergic systems in the mediation of apomorphine-stereotyped behaviour.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1973-10       Impact factor: 4.432

9.  Functional role of the nigro-neostriatal dopamine neurons.

Authors:  N E Andén; A Dahlström; K Fuxe; K Larsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

10.  Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Neuropharmacology       Date:  1973-05       Impact factor: 5.250
View more
  8 in total

1.  Further aspects of nomifensine pharmacology.

Authors:  B Costall; R J Naylor
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

2.  Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.

Authors:  B Costall; R J Naylor; J C Pettit
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Striatal dopamine and motor activity changes observed shortly after lithium administration.

Authors:  M E Otero Losada; M C Rubio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

4.  Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.

Authors:  B Costall; R J Naylor
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Circling induced by intra-accumbens amphetamine injections.

Authors:  L M Colle; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Pharmacological evidence for the subclassification of central dopamine receptors in the rat.

Authors:  A J Gower; A S Marriott
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

7.  The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954.

Authors:  D M Coward; N S Doggett
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

8.  Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice.

Authors:  P Worms; K Biziere
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.